Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 6:27 AM UTC
| NCT Number | NCT07763210 |
| Recruiting Status | Recruiting |
| Condition | Non-hodgkin Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 59 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 14, 2026: Clinical trial NCT07763210 is currently recruiting participants. This phase2 study for non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07763210 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07763210 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.